Precision Oncology with Genetic Tumor Profiling

Precision Oncology with Genetic Tumor Profiling: общие сведения

Precision oncology with genetic tumour profiling in India uses molecular information from a patient’s cancer to help identify treatment options that may be more relevant to the tumour’s biology. Testing can look for actionable mutations, gene fusions, amplifications, microsatellite instability, tumour mutational burden and other biomarkers that may influence targeted therapy, immunotherapy or clinical-trial eligibility. A molecular finding does not automatically mean that a specific medicine will work or be appropriate.

Evaluation usually begins with pathology review and assessment of the available tumour sample. Testing may use next-generation sequencing (NGS), PCR, FISH, immunohistochemistry or other validated methods depending on the cancer type and clinical question. In some cases, a liquid biopsy can be considered when tissue is unavailable or repeat sampling is difficult, although it does not replace tissue testing in every situation. Germline testing for inherited cancer risk is different from tumour-only profiling and may require genetic counselling.

Results should be interpreted in the context of cancer type, stage, previous treatment and current standard-of-care options. Some alterations have approved targeted medicines, while others are investigational or not clinically actionable. Multidisciplinary molecular tumour-board review can help prioritise meaningful findings and avoid overinterpreting uncertain variants.

The cost of genetic tumour profiling in India depends on test platform, panel size, tissue preparation, pathology review, liquid-biopsy use and oncology consultations. Medicines selected after testing are separate treatment costs.

India offers access to medical oncologists, molecular pathologists, genetics services and tertiary cancer centres with NGS and multidisciplinary review. Medical Help India can connect you with a suitable healthcare partner whose team can review pathology, prior treatment and existing molecular results and advise on appropriate next steps.

Как это работает